Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

Jesse C. Seegmiller; Emily L. Kokaisel; Steven J. Story; Christopher P. Zaun; Jennifer M. Peters; Stefani N. Thomas; Amy B. Karger

doi:10.1016/j.clinbiochem.2020.08.004

Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

Jesse C. Seegmiller, Emily L. Kokaisel, Steven J. Story, Christopher P. Zaun, Jennifer M. Peters, Stefani N. Thomas, Amy B. Karger

Laboratory Medicine and Pathology

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	34-35
Number of pages	2
Journal	Clinical Biochemistry
Volume	86
DOIs	https://doi.org/10.1016/j.clinbiochem.2020.08.004
State	Published - Dec 2020

Keywords

Antibody
COVID-19
Comparison
ELISA
SARS-CoV-2
Serology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.clinbiochem.2020.08.004

OpenUrl availability

Full text

Cite this

@article{d6ae00446c7944118ccd1bd304f058d6,

title = "Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay",

keywords = "Antibody, COVID-19, Comparison, ELISA, SARS-CoV-2, Serology",

author = "Seegmiller, {Jesse C.} and Kokaisel, {Emily L.} and Story, {Steven J.} and Zaun, {Christopher P.} and Peters, {Jennifer M.} and Thomas, {Stefani N.} and Karger, {Amy B.}",

year = "2020",

month = dec,

doi = "10.1016/j.clinbiochem.2020.08.004",

language = "English (US)",

volume = "86",

pages = "34--35",

journal = "Clinical Biochemistry",

issn = "0009-9120",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

AU - Seegmiller, Jesse C.

AU - Kokaisel, Emily L.

AU - Story, Steven J.

AU - Zaun, Christopher P.

AU - Peters, Jennifer M.

AU - Thomas, Stefani N.

AU - Karger, Amy B.

PY - 2020/12

Y1 - 2020/12

KW - Antibody

KW - COVID-19

KW - Comparison

KW - ELISA

KW - SARS-CoV-2

KW - Serology

UR - http://www.scopus.com/inward/record.url?scp=85089598928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089598928&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2020.08.004

DO - 10.1016/j.clinbiochem.2020.08.004

M3 - Letter

C2 - 32791053

AN - SCOPUS:85089598928

SN - 0009-9120

VL - 86

SP - 34

EP - 35

JO - Clinical Biochemistry

JF - Clinical Biochemistry

ER -

Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this